Hostname: page-component-78c5997874-94fs2 Total loading time: 0 Render date: 2024-11-19T23:29:26.115Z Has data issue: false hasContentIssue false
  • English
  • Français

Monitoring patient distress and related problems before and after hematopoietic stem cell transplantation

Published online by Cambridge University Press:  29 October 2013

Mary Crooks ,
Stuart Seropian ,
Mei Bai  and
Ruth McCorkle
Mary Crooks
Affiliation:
Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut
Stuart Seropian
Affiliation:
School of Medicine, Yale University, New Haven, Connecticut
Mei Bai
Affiliation:
School of Nursing, Yale University, New Haven, Connecticut
Ruth McCorkle
Affiliation:
School of Nursing, Yale University, New Haven, Connecticut
Get access Rights & Permissions [Opens in a new window]

Extract

Hematopoietic Stem Cell Transplantation (HSCT) is standard treatment for many high risk hematologic malignancies and non-malignant diseases either as part of overall treatment or after relapse. Both autologous and allogeneic transplant numbers are increasing worldwide (Storb, 2004). The procedure for transplantation is complex, can cause intense psychological distress, and extreme social strain on the patient, family members, and friends. There are times when the psychological and social issues can be more challenging for the health care team than the medical issues. Because HSCT is an intense and distinctive experience for patients and families and has the potential to cause prolonged psychological distress unlike other experiences with oncology patients, the issues unique to this population warrant special attention (Andrykowski, Brady, Henslee-Doeney, 1994, Andrykowski, 1994).

Type
Original Articles
Information
Palliative & Supportive Care , Volume 12 , Issue 1 , February 2014 , pp. 53 - 61
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Andrykowski, M., Brady, M., Henslee-Downey, P. (1994). Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosomatic Medicine. September 1, 56:432–439.Google Scholar
Andrykowski, M. (1994). Psychosocial factors in bone marrow transplantation: a review and recommendations for research. Bone Marrow Transplant 13:357–375.Google Scholar
Institute of Medicine (IOM). (2008). Cancer care for the whole patient: meeting psychosocial health needs, Adler, Nancy E. and Page, Ann E. K., eds. Washington, DC: The National Academies Press.Google Scholar
Jacobsen, PB., Wagner, LI. (2012). A new quality standard: The integration of psychosocial care into routine cancer. Journal of Clinical Oncology 0:1154–9.Google Scholar
Jacobsen, PB., Donovan, KA., Trask, PC., Fleishman, SB., Zabora, J., Baker, F., Holland, JC. (2005). Screening for psychologic distress in ambulatory cancer patients. Cancer 103:1494–1502.Google Scholar
National Comprehensive Cancer Network (NCCN). (2011). NCCN clinical practice guidelines in oncology: Distress management. Version 1.. Retrieved from http://www.nccn.org/professionals/physician_gls/pdf/distress.pdfGoogle Scholar
Ransom, S., Jacobsen, PB., Booth-Jones, M. (2006). Validation of the distress thermometer with bone marrow transplant patients. Psycho-Oncology 15: 604–612.CrossRefGoogle ScholarPubMed
Roth, AJ., Kornblith, AB., Batel-Copel, L., & Holland, J. (1998). Rapid screening for psychologic distress in men with prostate carcinoma. Cancer 82: 1904–08.Google Scholar
Storb, R. (2004). Allogeneic Hematopoietic Cell Transplantation: A Historical Perspective. Transfusion Medicine and Hemotherapy 31:21–32.Google Scholar